Compare ASMB & BSVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASMB | BSVN |
|---|---|---|
| Founded | 2005 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 414.7M | 393.6M |
| IPO Year | 2010 | 2018 |
| Metric | ASMB | BSVN |
|---|---|---|
| Price | $26.22 | $43.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $43.40 | ★ $53.33 |
| AVG Volume (30 Days) | ★ 98.7K | 12.0K |
| Earning Date | 03-19-2026 | 01-15-2026 |
| Dividend Yield | N/A | ★ 2.46% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.50 |
| Revenue | $37,191,000.00 | ★ $95,676,000.00 |
| Revenue This Year | $33.33 | $4.59 |
| Revenue Next Year | N/A | $7.19 |
| P/E Ratio | ★ N/A | $9.76 |
| Revenue Growth | ★ 31.30 | N/A |
| 52 Week Low | $7.75 | $32.49 |
| 52 Week High | $39.71 | $50.10 |
| Indicator | ASMB | BSVN |
|---|---|---|
| Relative Strength Index (RSI) | 43.34 | 48.38 |
| Support Level | $25.47 | $42.75 |
| Resistance Level | $27.50 | $45.67 |
| Average True Range (ATR) | 1.75 | 0.86 |
| MACD | 0.23 | -0.16 |
| Stochastic Oscillator | 35.04 | 34.70 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.